Free Newsletter
Pharma aids in Singapore manufacturing growth
Singapore's manufacturing industry expanded in June, the second time in as many months, with a boost from pharma output. The Purchasing Managers' Index, a leading indicator of manufacturing activity, turned positive in May for the first time in nine months, standing at 51.2. The trend continued in June, with a reading of 51.1. A reading above 50 indicates expansion, according to an announcement from Contact Singapore, an alliance of the Singapore Economic Development Board and Ministry of Manpower.
"The biomedical manufacturing sector expanded 120.4 percent year on year in May, thanks to a 138.6 percent leap in pharmaceutical output," the announcement says. A switch to higher-value patented drug compounds following U.S. approvals drove the increase, with help from a low base last May.
Electronics and aerospace manufacturing were also drivers.
- here's the release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: